2019
DOI: 10.1021/acs.orglett.9b00857
|View full text |Cite
|
Sign up to set email alerts
|

Late-Stage Diversification of Phosphinic Dehydroalanine Pseudopeptides Based on a Giese-Type Radical C-Alkylation Strategy

Abstract: A straightforward, late-stage diversification strategy for the installation of side chains on readily accessible unsaturated phosphinopeptidic scaffolds based on a Giese-type addition of alkyl radicals has been investigated. Among different alternatives, the preferred methodology is operationally simple as it can be carried out in an open flask with no need for protection of acidic moieties. Direct application to the synthesis of SPPS-compatible building blocks or to longer peptides is also reported.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…Another major concern that must be taken under consideration is that optimization opportunities strongly depend on synthetic advances in the field, ,,, as highlighted by the application of combinatorial chemistry principles in the discovery of selective inhibitors of several Zn-metalloproteases ,,, or the successful preparation of capricious sequences which allowed the synthesis of RXPA380 , or inhibitors of aminopeptidase A. , Finally, the transformation of phosphinic inhibitors of MMPs to molecular probes has set the basis for similar studies with other pharmacologically important Zn-metalloproteases, expanding the range of applications of this privileged class of tool compounds. Future development of novel, improved tool compounds or probes thereof will be largely accelerated by addressing unmet challenges such as stereoselective synthetic strategies, late-stage diversification approaches, or synthesis of unusual, conformationally constrained analogues. …”
Section: Future Perspectives and Conclusionmentioning
confidence: 99%
“…Another major concern that must be taken under consideration is that optimization opportunities strongly depend on synthetic advances in the field, ,,, as highlighted by the application of combinatorial chemistry principles in the discovery of selective inhibitors of several Zn-metalloproteases ,,, or the successful preparation of capricious sequences which allowed the synthesis of RXPA380 , or inhibitors of aminopeptidase A. , Finally, the transformation of phosphinic inhibitors of MMPs to molecular probes has set the basis for similar studies with other pharmacologically important Zn-metalloproteases, expanding the range of applications of this privileged class of tool compounds. Future development of novel, improved tool compounds or probes thereof will be largely accelerated by addressing unmet challenges such as stereoselective synthetic strategies, late-stage diversification approaches, or synthesis of unusual, conformationally constrained analogues. …”
Section: Future Perspectives and Conclusionmentioning
confidence: 99%